Literature DB >> 27241804

Eruptive nevi associated with medications (ENAMs).

Benjamin M Perry1, Anne Nguyen2, Bryce L Desmond3, Collin M Blattner4, R Scott Thomas3, R John Young3.   

Abstract

Eruptive melanocytic nevi have been reported in association with severe blistering diseases, renal transplantation, malignancy, AIDS, and medications. Eruptive nevi associated with medications have been reported with increasing frequency. Of particular interest are eruptive nevi associated with medications developing in association with biologic therapies, which we anticipate will continue to become more common as use of these medications continues to increase. We searched the databases PubMed/MEDLINE, Cochrane, and Cumulative Index to Nursing and Allied Health Literature for associated medications using the terms "eruptive nevi," "melanocytic + medications," and "nevi + medications" for relevant articles. We report the summary of our findings, which were used in defining what constitutes an eruptive nevi associated with medication and developing a classification system by medication type.
Copyright © 2016 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  adverse effects; azathioprine; combination chemotherapy; drug reactions; eruptive nevi; eruptive nevi associated with medications; medication reactions; medication-associated nevi eruptions; medication-associated reactions; melanocytic nevi; nevi; nevi eruptions; rituximab

Mesh:

Substances:

Year:  2016        PMID: 27241804     DOI: 10.1016/j.jaad.2016.04.064

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

1.  Sorafenib-Induced Eruptive Melanocytic Lesions.

Authors:  Hui-Chun Chen; Sheau-Chiou Chao
Journal:  Indian J Dermatol       Date:  2021 Nov-Dec       Impact factor: 1.494

2.  Eruptive lentigines confined to psoriatic plaques following biologic therapy.

Authors:  Urmi Khanna; Yasmine Oprea; Michael Fisher; Caroline Halverstam
Journal:  Clin Rheumatol       Date:  2022-07-11       Impact factor: 3.650

3.  Eruptive Melanocytic Nevi Secondary to Encorafenib for BRAF Mutant Metastatic Colorectal Cancer.

Authors:  Alberto Meneguzzo; Annalisa Lazzarotto; Mauro Alaibac
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

4.  Eruptive nevi after burn injury.

Authors:  Ali Tareen; Kristine Pallesen; Tine Vestergaard
Journal:  Dermatol Pract Concept       Date:  2018-01-31

5.  Eruptive melanocytic nevi associated with ponatinib.

Authors:  Inès Devred; Jean-Philippe Arnault; Alanoud Adas; Delphine Rea; Florian Lombart; Henri Sevestre; Stèphanie Trudel; Catherine Lok; Guillaume Chaby
Journal:  JAAD Case Rep       Date:  2018-11-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.